PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26026P0420IV gammagard LIQUID ERC - — Takeda Pharmaceuticals America Inc

Takeda Pharmaceuticals America Inc holds $6.5M across 96 federal awards, concentrated at Department of Justice (DOJ). This PIID sits alongside 3 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

260-Network Contract Office 20 (36C260)
Awarding office
Takeda Pharmaceuticals America Inc
Recipient
Sep 30, 2026
PoP end
$108K
Obligated
$108K
Potential
325412
NAICS
6505
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Takeda Pharmaceuticals America Inc — $90

Contract facts

NONE
Contract number36C26026P0420
Also listed as36C260-26-P-0420
Agency260-Network Contract Office 20 (36C260)
Awarding office260-Network Contract Office 20 (36C260)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentTakeda Pharmaceuticals America Inc
CAGE4DE70
UEIDDEVYUAXJ624
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Place of performanceLEXINGTON MA
Pricing typeFirm Fixed Price
Extent competedNot Competed Under SAP
PoP startApr 27, 2026
PoP end (current)Sep 30, 2026
Obligated$108K
Current value$108K
Potential value$108K

GAMMAGARD LIQUID ERC - GLOBULIN,IMMUNE (IV) 10% INJ is a federal NONE award for 260-Network Contract Office 20 (36C260) held by Takeda Pharmaceuticals America Inc. Estimated value $108K ($108K obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder. Place of performance: LEXINGTON MA.

GAMMAGARD LIQUID ERC - GLOBULIN,IMMUNE (IV) 10% INJ

Recompete timing

Public
Expiring in 40 days

Current PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Takeda Pharmaceuticals America Inc$6.5M obligated across 96 awards (firm-wide, all agencies) · lead buyer Department of Justice (DOJ).

% of firm-wide obligated ($6.5M) · all agencies
Department of Justice (DOJ)$4.0M · 62%Department of Veterans Affairs (VA)$2.5M · 38%Department of Defense (DOD)$20K · 0%
Open full company profile

Related awards

Same incumbent
15B50926F00000076
FY26 PHARMACEUTICALS TAKEDA APRIL-SEPTEMBER
$549K
Sep 30, 2026
15B50926F00000018
FY26 TAKEDA OCT-NOV
$320K
Sep 30, 2026
36C26026F0130
ADZYNMA 1500IU INJ,LYPHL.
$179K
Jan 3, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C26026P0420?

36C26026P0420 (IV gammagard LIQUID ERC -) is a 260-Network Contract Office 20 (36C260) award with a potential value of $108K, currently held by Takeda Pharmaceuticals America Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C260-26-P-0420?

36C260-26-P-0420 is the dashed form of PIID 36C26026P0420 (IV gammagard LIQUID ERC -), held by Takeda Pharmaceuticals America Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26026P0420?

260-Network Contract Office 20 (36C260) awarded 36C26026P0420 to Takeda Pharmaceuticals America Inc (potential $108K).

Who is the incumbent on 36C26026P0420?

Takeda Pharmaceuticals America Inc is the incumbent with $6.5M across 96 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Takeda Pharmaceuticals America Inc’s 36C26026P0420 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C26026P0420